Case Study: Female. aged 64. None smoker.  

A late-stage lung cancer patient underwent treatment with GcMAF with a team of 50 doctors, under one roof, working together for more positive outcomes and studies.  

 She received 2500ng daily subcutaneously and 0.5ml daily through a nebulizer for 3 months. •  Intravenous therapy designed by a team of doctors, administered in a hospital environment under medical supervision for 6 weeks.  

 After 11 months, she made a complete recovery. Here are the key points of her treatment and recovery: 

• Day 5: Notablereduction in coughing by day 5. 
• Day 9: Permanent lung drain removed after 9 days of treatment, with no further drainage      required. 
• Day 12: Oxygen levels increased by 20%. 
• No chemotherapy or surgical intervention needed. 
• After 3 months, her color returned, energy levels increased, she gained weight, had zero cough, and was able to take full deep breaths. Imagery confirmed 80% reduction in tumor size.
•  After 14 Months: Imagery proved that cancer was no longer present. Status of remission was    awarded.  
• 5 Year check-up: Deep remission status Granted. No further check-up required.

 This case highlights the potential benefits of GcMAF in treating late-stage lung cancer, offering a non-invasive and effective alternative to traditional treatments. 

50 year old Mr Stone from Mexico was diagnosed with advanced cancer lung (stage 4) in late February of 2020 (adenocarcinoma – never smoked) and started on chemotherapy at another outside hospital. Following his 6 weekly dose, he worsened and came to the 50 doctors for a second opinion, where he met with Dr Celma and the team.

Dr. Celma spent time reviewing the biopsy from the previous hospital.
He observed that Mr Stones’ biopsy was inadequate to complete mutation testing. His EGFR mutations testing, this is very important to conduct in lung cancer, especially in no smokers, The test had failed due to technical reasons. However, his condition kept worsening.

He finally decided to take treatment with Dr Celma.

When he came, he was breathless and required 24 hour hour oxygen support, which had to be optimized.

CT Chest showed lymphangitis carcinomatosis with large lung mass /tumour on the right side and pleural effusion.

Xray chest on 17.02.2020 showed fluid in the lung he marked this with a (Red arrow), Large opaque lung mass which he marked with a (blue arrow), multiple numerous small lung nodules (lymphangitis carcinomatosis – miliary shadows in both lung fields), he marked this with a red circle.

He was started on 2500ng of GcMaf sub C daily, 1250ng of GcMAF Nebulised daily, pure. Fenbendazole and Ivermectin (triple drug combination) became part of the protocol with regular adjusted dosages. An I.V protocol designed with vitamins and minerals was added, light therapy and magnet therapy were also added to optimize his general condition. (This protocol was tested in a previous small scale, study )
In 10 days.
A vegan diet from highly nutritional green juice was given.

Key points:

Day 28: his X-ray showed small improvement.

Day 28, just before his second cycle, he was no longer requiring oxygen support.

He was independent, walking and climbing stairs comfortably.

3 months later: His X ray after 3 monthly cycles showed miraculous improvement – effusion disappeared, lung mass almost dissolved away, and lung fields were clear off miliary nodules.

This case highlights the potential benefits of alternative therapies in a controlled environment.